Loading…
Embed AI into SaaS · Philadelphia
The Philadelphia and Princeton-corridor SaaS ecosystem concentrates in three industries where AI features have to ship with serious documentation. Pharma SaaS adjacent to GSK, Merck, and the Penn biotech cluster (IQVIA tech, Veeva-adjacent, clinical-trial platform vendors) needs FDA validation packages. FinTech SaaS in the corridor (Vanguard tech, Susquehanna International, SEI tech) needs SR 11-7 model-risk documentation. Defense SaaS at Lockheed Martin Moorestown needs CMMC and ITAR-aware deployment. HealthTech SaaS selling into Penn, Jefferson, and CHOP needs both HIPAA architecture and AI governance documentation.
We embed AI features into these SaaS products with the validation, model-risk, and governance documentation in the box from day one. Not bolted on after procurement asks the question, not deferred to a future version. We have shipped this pattern for pharma clinical-trial SaaS, FinTech compliance tools, and HealthTech revenue-cycle platforms.
Fixed-scope projects, scoped to the regulatory frame your customer segment requires. Discovery includes a regulatory walkthrough with your compliance, model-risk, or quality team.
Tell us about the SaaS and the regulatory frame.
For pharma SaaS the architecture includes a validation package. Installation Qualification documents the deployment, Operational Qualification is the eval harness with recall and accuracy metrics on a labeled set, Performance Qualification runs shadow traffic against a labeled ground truth before cut-over. 21 CFR Part 11-compatible audit trail. Pinned model versions in configuration. Change-control SOP shipped with the codebase.
For FinTech SaaS the architecture supports SR 11-7 model-risk review. Model inventory with specific provider, version, and parameter settings. Workflow-scope documentation. Validation set performance benchmarks. Drift monitoring through OpenTelemetry traces. Documented rollback procedure. This is what model-risk teams and OCC examiners ask for when reviewing AI features in financial-services contexts.
For defense SaaS the architecture routes inference through AWS GovCloud Bedrock or Azure Government OpenAI under FedRAMP and CMMC accreditation. Model weights stay inside the GovCloud or Azure Gov boundary. Data never crosses into commercial-cloud inference. Audit logging matches the CMMC SC-12, SC-13, and AU-12 controls. For ITAR-controlled technology the AI features ship inside an ITAR-marked environment with USPER access controls.
For HealthTech SaaS selling to academic medical centers the architecture is HIPAA-aware (BAA-covered model routing, PHI redaction, BAA-covered observability) plus governance-ready documentation: model card with capability and limitation summary, intended-use statement, contraindication list, eval set scenarios and outcomes. Penn Medicine, Jefferson, and CHOP each have AI governance processes that ask for this documentation during procurement.
Across all of these frames the embed approach is the same. Work inside the existing codebase. Use the existing DI container, import path, and UI framework. Add the regulatory architecture as documented layers, not as parallel stacks. Ship the validation, model-risk, or governance pack with the build.
Six components that show up in every regulated-SaaS AI feature we embed in the metro.
Installation, Operational, and Performance Qualification documentation. Labeled eval set as OQ, shadow-traffic comparison as PQ, deployment topology as IQ. 21 CFR Part 11 audit trail.
Model inventory with provider, version, parameters. Workflow scope, performance benchmarks, drift monitoring, rollback procedure. Documentation matches OCC examination expectations.
AWS GovCloud Bedrock or Azure Government OpenAI for defense and federal-adjacent SaaS. Model weights stay inside GovCloud boundary. CMMC SC-12, SC-13, AU-12 audit alignment.
Bedrock Claude under Anthropic BAA or Azure OpenAI under Microsoft BAA for HealthTech tenants. PHI redaction in prompt construction. Public APIs never reached when PHI in scope.
Model card with capability and limitation summary, intended-use statement, contraindication list, eval set scenarios. Built for academic medical center procurement reviews.
Per-tenant configuration that loads the right regulatory frame: validation pack for pharma tenants, model-risk pack for FinTech, governance pack for AMC HealthTech. Same SaaS can serve multiple.
Philadelphia and the Princeton corridor SaaS economy builds around customer segments where AI features have to ship with documentation. Pharma SaaS selling into GSK, Merck, and Spark Therapeutics. FinTech SaaS adjacent to Vanguard, Susquehanna, and SEI. HealthTech SaaS selling into Penn, Jefferson, CHOP, and the broader academic-medicine ecosystem. Defense SaaS at Lockheed Martin Moorestown and the wider Mid-Atlantic defense cluster.
The procurement frame is what kills under-documented AI features in this metro. A pharma customer's quality team will not approve an AI feature without OQ documentation. A FinTech customer's model-risk team will not approve without an SR 11-7 pack. An AMC will not approve a HealthTech AI feature without the governance documentation. We design the architecture and the documentation together so the SaaS team does not lose six-figure deals on missing paperwork.
We work remotely with Philadelphia and Princeton-corridor clients on Eastern time. Discovery includes a regulatory walkthrough with your customer's expected compliance frame.
Industries where we see strongest fit: clinical-trial and regulatory-affairs pharma SaaS, FinTech selling into asset managers and brokerages, HealthTech selling into academic medical centers, defense and federal-adjacent SaaS, and EdTech selling into Drexel, Penn, and broader higher-ed.
Describe the SaaS, the feature, and your largest customer segment's regulatory frame. We'll reply within one business day with a rough scope and a price range.